All lobbying filings
Roberti Global (FKA Roberti White, LLC)
Roberti Global (FKA Roberti White, LLC) filed a Q4 report for Biotechnology Innovation Organization (Bio) on January 20, 2026, reporting $60,000 in lobbying income.
Lobbying for Biotechnology Innovation Organization (Bio) · Trade association
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Government bodies contacted
2
Lobbying activity
3
Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).
Issues related to drug pricing, generally; 340B Drug Pricing Program; pharmacy benefit managers; drug patents and patent reporting requirements; H.R. 1262/S. 932, Give Kids a Chance Act.
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.